1. Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression. Issue 2 (6th January 2023) Authors: Peddi, V. Ram; Marder, Bradley; Gaite, Luis; Oberholzer, Jose; Goldberg, Ryan; Pearson, Thomas; Yang, Harold; Allamassey, Lisa; Polinsky, Martin; Formica, Richard N. Journal: Transplantation direct Issue: Volume 9:Issue 2(2023) Page Start: e1419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗